February 20, 2014 — Guerbet, a contrast agent specialist for medical imaging, received U.S. Food and Drug Administration ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
January 31, 2014 — Researchers at the University of North Carolina at Chapel Hill have achieved higher resolution ...
December 18, 2013 — For the first time, researchers have confirmed an association between a common magnetic resonance ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
November 26, 2013 — Researchers say they have achieved enough coherence of the magnetic moment inherent in the defects ...
November 22, 2013 – GE Healthcare announced today that it has received approval from the U.S. Food and Drug ...
November 15, 2013 — Guerbet announced that Novation, a health care supply chain expertise, analytics and contracting ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
November 13, 2013 – No law prevents doctors from freely prescribing U.S. Food and Drug Administration (FDA)-approved ...
October 21, 2013 – Guerbet announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug ...
October 3, 2013 — The Arthritis Foundation awarded $1 million to the Hospital for Special Surgery in New York City ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
September 5, 2013 — Scientists at Rice University have trapped bismuth in a nanotube cage to tag stem cells for X-ray ...
July 30, 2013 — Guerbet has announced that Cincinnati Children's Hospital Medical Center (Cincinnati Children's) last ...
Peter Herscovitch, M.D., SNMMI president-elect, explains the advances in molecular imaging for Alzheimer's disease and ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
May 16, 2013 — Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems ...
May 13, 2013 — A new method of dynamic, personalized intravenous hydration significantly reduces the percentage of ...
March 21, 2013 -- Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate ...
March 14, 2013 — Lantheus Medical Imaging Inc. announced the U.S. Food and Drug Administration (FDA) has granted ...
March 12, 2013 — Many physicians have long believed that the use of intravenous contrast agents for computed tomography ...
February 20, 2013 — Guerbet announced that the Medical Imaging Drugs Advisory Committee to U.S. Food and Drug ...
February 7, 2013 — Performing heart surgery on the same day as angiography is now confirmed as a risk factor for acute ...
January 18, 2013 — GE Healthcare announced that it has filed a supplemental new drug application (sNDA) that will allow ...
February 20, 2014 